Bladder Cancer Detection Videos

Blue Light Cystoscopy Delays Time To Recurrence in NMIBC Patients Treated in a Real-World Setting - Sia Daneshmand

Details
Sam Chang and Sia Daneshmand explore the impact of Cysview blue light cystoscopy on cancer recurrence. Dr. Daneshmand presents a comprehensive registry study from USC which shows significantly lower recurrence rates in patients examined with blue light cystoscopy, when compared to a white light patient group. Notwithstanding potential variables like modern management techniques, they attribute thi...

Optimal TURBT: Do Skilled Urologists Really Need Photodynamic Diagnosis (PDD)? -Trinity Bivalacqua & Michael Cookson

Details
The 2023 AUA annual meeting included the Bladder Cancer Forum, featuring a debate discussing whether skilled urologists need photodynamic diagnosis (PDD) to perform an optimal TURBT. Drs. Michael Cookson and Trinity Bivalacqua, who were participants in this debate, join Dr. Neal Shore to highlight the takeaways from the session. Cookson argued against the use of blue light due to the limitations a...

Reduction in the Risk of Recurrence with the Use of Blue Light Cystoscopy Use Among Patients with Non-Muscle Invasive Bladder Cancer In An Equal Access Setting - Stephen Williams

Details
Sam Chang is joined by Stephen Williams to discuss the impact of Blue Light Cystoscopy (BLC) use among patients with non-muscle invasive bladder cancer (NMIBC) in an equal access setting, specifically the Veterans Affairs (VA) system. Prior studies suggest that white light cystoscopy (WLC) alone can fail to detect cases of NMIBC compared to BLC. Dr. Williams explains that they found a roughly 30%...

From Science to Clinical Utility: Cxbladder Detect - Bladder Cancer Detection for Patients Who Present with Hematuria - Tamer Aboushwareb, Neal Shore & Josh Meeks

Details
Tamer Aboushwareb, Vice President of Medical Affairs, Pacific Edge, Ltd provides an overview of the Cxbladder Detect urine-based cancer diagnostic test and is joined by Neal Shore and Josh Meeks for a discussion on the clinical implications of the use of this test which is designed for high-risk patients who present with hematuria. Cxbladder is a suite of non-invasive, urine-based laboratory tests...

Blue Light Powered by Saphira® for the Detection of Non Muscle-Invasive Bladder Cancer - Max Kates & Trinity J. Bivalacqua

Details
In this discussion, Max Kates and Trinity Bivalacqua join Ashish Kamat in reviewing Blue Light Cystoscopy (BLC®) with Cysview®, specifically highlighting the New Blue Light Powered by Saphira® providing next-level visualization being used with Photocure’s Cysview® product in BLC® procedures for the detection of non‐muscle invasive bladder cancer (NMIBC). The new Blue Light system was approved on F...

Blue Light Cystoscopy with Cysview® & Adjuvant Perioperative Chemotherapy for Nonmuscle-Invasive Bladder Cancer - Sia Daneshmand & Trinity Bivalacqua

Details
In this discussion, Ashish Kamat moderates a debate between Sia Daneshmand and Trinity Bivalacqua comparing the benefits of enhanced cystoscopy with blue light cystoscopy in TURBT to the benefits of perioperative chemotherapy following TURBT. Dr. Daneshmand discusses the role of blue light cystoscopy (BLC ®) in TURBT that there is an improvement in detecting tumors and their respective margins dur...

Realities of Bladder Cancer In Women - Sima Porten, Kristen Scarpato, Svetlana Avulova & Anne Schuckman

Details
Kristen Scarpato, Svetlana Avulova, and Anne Schuckman join Sima Porten in this conversation on the realities of diagnosis and treatment of bladder cancer in women. They start by evaluating a patient case to highlight some women who present with bladder cancer and discuss what's most important when we talk about caring for these patients and how to improve care. Biographies: Sima P. Porten, MD, MP...

Treating Women with Bladder Cancer and a Community Approach to Navigating a Diagnosis - Jeannie Hoffman-Censits & Elizabeth Guancial

Details
Alicia Morgans is joined by Jeannie Hoffman-Censits and Elizabeth Guancial to discuss the challenges women face navigating a bladder cancer diagnosis. In 2022, the American Cancer Society estimates more than 81,000 will be diagnosed with bladder cancer in the United States. Of those, 61,700 will be men, and 19,480 will be women. Drs. Morgans, Hoffman-Censits, and Guancial discuss the importance of...

Current and Emerging Therapies for Non-Muscle Invasive Bladder Cancer after BCG - Chris Wallis & Zach Klaassen

Details
For this Journal Club, Christopher Wallis, MD, and Zach Klasseen, MD discuss a recently published meta-analysis on treatment options for patients with non-muscle invasive bladder cancer unresponsive or refractory to BCG therapy. They provide context for this review and discuss the clinical relevance of managing the risk of recurrence in NMIBC. Biographies: Zachary Klaassen, MD, MSc, Urologic Oncol...

Role of Blue Light Cystoscopy in Detecting Invasive Bladder Tumor - Sia Daneshmand

Details
Siamak (Sia) Daneshmand joins Ashish Kamat in a discussion on the role of blue-light cystoscopy (BLC) in detecting invasive bladder tumors. Providing background on the beneficial use of BLC in carcinoma in situ (CIS), Dr. Daneshmand highlights the evidence on the potential of finding additional TA tumors with the use of BLC. He showcases data from a BJUI multi-institutional registry publication on...